onyx-015
Biologicalexperimental
Adenovirus varieties have been explored extensively as a viral vector for gene therapy and also as an oncolytic virus. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1999 (NCT00006106)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaOncolytic adenovirus ↗
Also known as
- ci1042
- ci-1042
- dl1520
- onyx015
- onyx-015
- onyx-015
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00006106 | Phase 1 | Jul 1, 1999 | Harvard University, National Cancer Institute (NCI) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 1999 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 1999 |
2 organizations
Page 1 / 1